Back to search
FDAFDA · Food and drugs·Recall number D-0992-2020

Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 1,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0210-3

Published March 11, 2020 · Recall initiated: January 15, 2020

Summary

FDA records drug Class II recall D-0992-2020, published March 11, 2020 and initiated January 15, 2020. Recalling firm: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 04082019+51930, Exp 4/8/2020; 09092019+52891, Exp 8/12/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Distributor
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Lot
Lot #: 04082019+51930, Exp 4/8/2020; 09092019+52891, Exp 8/12/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 1,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0210-3 recalled?

Yes. FDA published recall D-0992-2020 on March 11, 2020. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release